" class="no-js "lang="en-US"> Albert Bourla Archives - Medtech Alert
Friday, January 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease | MTA

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Read more

COVID-19

 Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron | Pharmtech Focus

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]

COVID-19

 Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. | Pharmtech Focus

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States […]

Appointments

 Pfizer Names David M. Denton Chief Financial Officer | Pharmtech Focus

Pfizer Names David M. Denton Chief Financial Officer

Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as […]

COVID-19

 Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19 | Pharmtech Focus

Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19

Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 […]

COVID-19

 Pfizer and Biontech Expand Collaboration with U.S. To Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries | Pharmtech Focus

Pfizer and Biontech Expand Collaboration with U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to expand their […]

Appointments

 Pfizer Announces New Chief Business Innovation Officer Aamir Malik | Pharmtech Focus

Pfizer Announces New Chief Business Innovation Officer Aamir Malik

Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive […]

COVID-19

 Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older | Pharmtech Focus

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older

Pfizer Inc.and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) approved […]

COVID-19

 Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. | Pharmtech Focus

Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of Covid-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government […]

COVID-19

 Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa | Pharmtech Focus

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent […]

Appointments

 Pfizer Announces New Investor Relations Leader | Pharmtech Focus

Pfizer Announces New Investor Relations Leader

Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more